Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape

DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015” to its portfolio.
By: DelveInsight Business Research
 
DWARKA, India - Nov. 16, 2015 - PRLog -- The Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015 report provides the client with details on the ongoing enterprises and the upcoming business opportunities related to new interventions. It comprehensively includes:

· 200+ products and 60+ different technologies along with 160+ companies actively involved in drug development. There are 5 drugs in phase III, 17 in phase II, 44 in phase I, 83 in pre-clinical, 33 in discovery, 13 in dormant and 18 in discontinued.

· Seattle Geneticsis developing a lead product Brentuximab Vedotin which is in Phase III.

· R&D activities and technologies used along with the pipeline molecules in development.

· Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.

· Information related to collaborations, in-licensing and out-licensing deals.

DelveInsights, Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015report provides the in-depth analysis of Antibody Drug Conjugate Landscape across the globe. Therefore the report on Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provide information on chemical, technology information and comparative analysis at various stages. In addition, it helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight is offering the Report at a price of USD 3450 as a single user license, USD 6900 as a site license and USD 10000 as a Global/Enterprise License.

For more information on Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015report, email at info@delveInsight.com

About Us

DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

Contact
DelveInsight Business Research
***@delveinsight.com
End
Source:DelveInsight Business Research
Email:***@delveinsight.com Email Verified
Tags:DelveInsight, Antibody, Conjugate
Industry:Business
Location:Dwarka - Delhi - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
DelveInsight PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share